Page last updated: 2024-09-03

sk&f 104856 and terazosin

sk&f 104856 has been researched along with terazosin in 2 studies

Compound Research Comparison

Studies
(sk&f 104856)
Trials
(sk&f 104856)
Recent Studies (post-2010)
(sk&f 104856)
Studies
(terazosin)
Trials
(terazosin)
Recent Studies (post-2010) (terazosin)
1400658173104

Protein Interaction Comparison

ProteinTaxonomysk&f 104856 (IC50)terazosin (IC50)
Alpha-2B adrenergic receptorHomo sapiens (human)0.428
Alpha-2C adrenergic receptorHomo sapiens (human)6.042
Alpha-1D adrenergic receptorHomo sapiens (human)0.011
Alpha-1A adrenergic receptorHomo sapiens (human)0.005
Alpha-1B adrenergic receptorHomo sapiens (human)0.005

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballard, S; Blagg, J; Fox, D; Kenny, B1
Pedretti, A; Testa, B; Villa, L; Vistoli, G1

Reviews

1 review(s) available for sk&f 104856 and terazosin

ArticleYear
Pharmacological options in the treatment of benign prostatic hyperplasia.
    Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship

1997

Other Studies

1 other study(ies) available for sk&f 104856 and terazosin

ArticleYear
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
    Journal of medicinal chemistry, 2005, Jul-28, Volume: 48, Issue:15

    Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents

2005